The effect of functionalizing lipid nanocapsules with NFL-TBS.40-63 peptide on their uptake by glioblastoma cells

Biomaterials

Volumn 34, Issue 13, 2013, Pages 3381-3389

  Balzeau, Julien ^a   Pinier, Maud ^a   Berges, Raphael ^a   Saulnier, Patrick ^a   Benoit, Jean Pierre ^a   Eyer, Joel ^a  

^a UNIVERSITÉ D'ANGERS   (France)

Author keywords

Glioblastoma; Lipid nanocapsules; NFL TBS.40 63 peptide; Paclitaxel

Indexed keywords

CELL-PENETRATING PEPTIDE; DROP TENSIOMETRY; FLUOROCHROMES; FUNCTIONALIZED; GLIOBLASTOMA CELLS; GLIOBLASTOMAS; IN-VITRO; LIPID NANOCAPSULES; MICROTUBULE NETWORKS; NEUROFILAMENTS; PACLITAXEL; TARGETED TREATMENT;

CELLS; CYTOLOGY; PEPTIDES; TUMORS;

NANOCAPSULES;

CELL PENETRATING PEPTIDE; DRUG CARRIER; FLUOROCHROME; NANOCAPSULE; PACLITAXEL; PEPTIDE NFL-TBS.40-63; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; ASTROCYTE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG POTENTIATION; DRUG TARGETING; DRUG UPTAKE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GLIOBLASTOMA; GLIOMA CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALS; ASTROCYTES; BRAIN; BRAIN NEOPLASMS; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; GLIOBLASTOMA; LIPIDS; MICE; MICE, INBRED C57BL; NANOCAPSULES; NEUROFILAMENT PROTEINS; PACLITAXEL; PEPTIDE FRAGMENTS; PROTEIN BINDING;

MUS;

EID: 84874259731     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.01.068     Document Type: Article

References (22)

1. Stupp R., Roila F. Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009, 20:126-128.
2. Stupp R., Hegi M.E., Mason W.P., van den Bent M.J., Taphoorn M.J., Janzer R.C., et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009, 10:459-466.
3. Delion M., Moraru C., Almayrac F., Von Langsdorff D., Paquis P., Menei P. Glioblastoma incident studies from May 2006 to May 2007 in Angers and Nice, France. Neurochirurgie 2010, 56:499-502.
4. Delgado G., Potkul R.K., Treat J.A., Lewandowski G.S., Barter J.F., Forst D., et al. A phase I/II study of intraperitoneally administered doxorubicin entrapped in cardiolipin liposomes in patients with ovarian cancer. Am J Obstet Gynecol 1989, 160:812-819.
5. Lammers T., Hennink W.E., Storm G. Tumour-targeted nanomedicines: principles and practice. Br J Cancer 2008, 99:392-397.
6. Menei P., Capelle L., Guyotat J., Fuentes S., Assaker R., Bataille B., et al. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of malignant glioma: a randomized phase II trial. Neurosurgery 2005, 56:242-248.
7. Salvati M., D'elia A., Frati A., Brogna C., Santoro A., Delfini R. Safety and feasibility of the adjunct of local chemotherapy with biodegradable carmustine (BCNU) wafers to the standard multimodal approach to high grade gliomas at first diagnosis. J Neurosurg Sci 2011, 55:1-6.
8. Muthu M.S., Kulkarni S.A., Xiong J., Feng S.S. Vitamin E TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. Int J Pharm 2011, 421:332-340.
9. Heurtault B., Saulnier P., Pech B., Proust J.E., Benoit J.P. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res 2002, 19:875-880.
10. Garcion E., Lamprecht A., Heurtault B., Paillard A., Aubert-Pouessel A., Denizot B., et al. A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Mol Cancer Ther 2006, 5:1710-1722.
11. Vanpouille-Box C., Lacoeuille F., Belloche C., Lepareur N., Lemaire L., LeJeune J.J., et al. Tumor eradication in rat glioma and bypass of immunosuppressive barriers using internal radiation with (188)re-lipid nanocapsules. Biomaterials 2011, 28:6781-6790.
12. Huynh N.T., Morille M., Bejaud J., Legras P., Vessieres A., Jaouen G., et al. Treatment of 9L gliosarcoma in rats by ferrociphenol-loaded lipid nanocapsules based on a passive targeting strategy via the EPR effect. Pharm Res 2011, 28:3189-3198.
13. Said Hassane F., Saleh A.F., Abes R., Gait M.J., Lebleu B. Cell penetrating peptides: overview and applications to the delivery of oligonucleotides. Cell Mol Life Sci 2010, 67:715-726.
14. Bocquet A., Berges R., Frank R., Robert P., Peterson A.C., Eyer J. Neurofilaments bind tubulin and modulate its polymerization. J Neurosci 2009, 29:11043-11054.
15. Berges R., Balzeau J., Peterson A.C., Eyer J. A tubulin binding peptide targets glioma cells disrupting their microtubules, blocking migration and inducing apoptosis. Mol Ther 2012, 20:1367-1377.
16. McCarthy K.D., de Vellis J. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 1980, 85:890-902.
17. Minkov I., Ivanova T., Panaiotov I., Proust J., Saulnier P. Reorganization of lipid nanocapsules at air-water interface. I. Kinetics of surface film formation. Colloids Surf B Biointerfaces 2005, 45:14-23.
18. Balzeau J., Peterson A.C., Eyer J. The vimentin-tubulin binding site peptide (Vim-TBS.58-81) crosses the plasma membrane and enters the nuclei of human glioma cells. Int J Pharm 2012, 423:77-83.
19. Berges R., Balzeau J., Takahashi M., Prevost C., Eyer J. Structure-function analysis of the glioma targeting NFL-TBS.40-63 peptide corresponding to the tubulin-binding site on the light neurofilament subunit. PLOS One 2012, Available from: URL:. http://www.ncbi.nlm.nih.gov/pubmed/23152907, 10.1371/journal.pone.0049436.
20. Soda Y., Marumoto T., Friedmann-Morvinski D., Soda M., Liu F., Michiue H., et al. Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci U S A 2011, 108:4274-4280.
21. Allard E., Huynh N.T., Vessieres A., Pigeon P., Jaouen G., Benoit J.P., et al. Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model. Int J Pharm 2009, 379:317-323.
22. Vichon-Petit S., Jarnet D., Paillard A., Benoit J.P., Garcion E., Menei P. In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: distribution and radiosensitisation efficacy. J Neurooncol 2010, 97:195-205.